Thirteen students from the International Biomedical Regulatory Sciences program received master’s degrees or graduate certificates in Regulatory Sciences at the completion of the spring 2023 semester, announced Dr. Grace Gowda, Director of IBRS.
“We are proud of our graduating students, who are committed to the healthcare profession and the development of innovative medicines that will support their communities and beyond,” said Dr. Gowda. “As the biomedical industry rapidly expands, regulatory science professionals are needed. I am confident of the contributions these individuals will make due to the excellent education and training they have received from the faculty in our program.”
Housed at the UGA Gwinnett campus in Lawrenceville, the IBRS program is designed to prepare regulatory sciences professionals for careers in the medical device, pharmaceutical, biologics, and animal health business sectors. Graduates become professionals who are critical to the development, manufacturing, and marketing of safe and effective medical drugs and products. Web-based, part-time instruction is taught by experts from industry, the university, and regulatory agencies to assure that curricula is relevant and current to the field. Flexibility in the course work allows participants to earn a master’s degree or certificate while working or pursuing other educational pathways.
Recipients of graduate degrees and certificates include:
Master’s Degree in Regulatory Sciences
- Andrew Partain
- Bryan Soto (PhD, Chemistry, UGA, 2019)
Graduate Certificates in Regulatory Sciences
- Emily Davis (Candidate, PharmD, 2024)
- Phillip Dean (Candidate, PhD in Pharmaceutical and Biomedical Sciences, 2025; Candidate, Clinical Trials Design & Management Certificate, summer 2023)
- Jake Forcier (Candidate, Master’s in Pharmaceutical and Biomedical Sciences, 2024)
- Ashlee Harvey (Candidate, PharmD, 2024)
- Taylor S. Jones (Candidate, Master’s in International and Biomedical Sciences, 2024)
- Shylock Mafu (Candidate, Master’s in International and Biomedical Sciences, 2024)
- Makienze Moore (Candidate, PharmD, 2024)
- Yue (Michelle) Rao (Candidate, PharmD, 2024)
- Kelsie Sapp (Candidate, PharmD, 2025)
- Kayla Ward (Candidate, PharmD, 2024)
- Sarah Wilson
For further information about the IBRS program, contact Dr. Grace Gowda.